BAY1192631
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY1192631, covering 2018-10-04 to 2018-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections [Phase 3]